期刊文献+

两性霉素B对感染口腔假丝酵母菌的失效性分析 被引量:3

Amphotericin B to Infection of Oral Candida Failure Analysis
下载PDF
导出
摘要 目的:分析两性霉素B对医院口腔感染假丝酵母菌的失效性。方法:给予830例口腔感染患者两性霉素B治疗,初始3d的剂量是1、3、5 mg,加入5%葡萄糖溶液40 mg,保持速度是4 mL/h,从第4天开始每日增加4 mg,直至20 mg,后续保持该剂量;持续1~3个月的疗程,总用药量是1~1.5 g,并采用假丝酵母菌R因子检测方法分析两性霉素B对感染口腔假丝酵母菌的失效性。结果:从60株多重抗药性假丝酵母菌中分离出39株R因子,阳性率为65.5%,40株假丝酵母菌R因子的抗药性基因结构中3种以上抗药性基因者占有90%;结论:假丝酵母菌对两性霉素B的抗药性与传递R因子具有较强的关联性,利用R因子对两性霉素B对感染口腔假丝酵母菌失效性的分析具有安全和高效性的特征。 Objective:to analyze amphotericin B for hospital oral cavity infection of candida of failure. Method:830 cases of oral infection patients' amphotericin B therapy, the dose of initial 3 d is 1, 3, 5 mg and 40 mg in 5%glucose solution, maintain speed is 4 ml/h, starting from the fourth day on 4 mg per day, until 20 g, subsequent keep the dose; Last 1 to 3 months of treatment, the total dose is 1-1.5 g, and USES the candida R factor analysis of amphotericin B test method for the failure of oral candida infection. Results:from 60 strains of multidrug-resistant 39 strains of candida isolated R fac-tor, positive rate was 65.5%, 40 strains of candida R factor resistance gene structure of the above three kinds of resistant genes accounts for 90%; Candida. Conclusion:the resistance of amphotericin B with the transfer of R factor has strong correlation, by using R factor of amphotericin analysis of the failure of oral candida infection sex has the characteristics of safety and efficiency.
出处 《科技通报》 北大核心 2014年第2期22-24,30,共4页 Bulletin of Science and Technology
关键词 两性霉素B 感染口腔 假丝酵母菌 失效性 amphotericin B oral infection candida lose efficacy
  • 相关文献

参考文献6

二级参考文献25

  • 1Denning DW,Kibbler CC,Barnes RA.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections[J].Lancet Infect Dis,2003,3(4):230-240.
  • 2Pfaller MA,Pappas PG,Wingard JR.Invasive fungal pathogens current epidemiological trends[J].Clin Infect Dis,2006,43(1):S3-S14.
  • 3Shen YZ,Qi TK,Ma JX,et al.Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital[J].Mycoses,2007,50(6):475-480.
  • 4Patterson TF.Advances and challenges in management of invasive mycoses[J].Lancet,2005,366(9490):1013-1125.
  • 5Lai CC,Tan CK,Huang YT,et al.Current challenges in the management of invasive fungal infections[J].J Infect Chemother,2008,14(2):77-85.
  • 6Gueret R,Patel GR,Simon D.Invasive aspergillosis case report and review of the approach to diagnosis and treatment[J].Clin Pulm Med,2007,14(3):197-205.
  • 7Montagna MT,Caggiano G,Borghi E,et al.The role of the laboratory in the diagnosis of invasive candidiasis[J].Drugs,2009,69 (Suppl 1):59-63.
  • 8Erjavec Z,Kluin-Nelemans H,Verweij PE.Trends in invasive fungal infections,with emphasis on invasive aspergillosis[J].Clin Microbiol Infect,2009,15(7):625-633.
  • 9Bialek R,Konrad F,Kern J,et al.PCR based identi-fication and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue[J].J Clin Pathol,2005,58(11):1180-1184.
  • 10Procop GW.Molecular diagnostics for the detection and characterization of microbial pathogens[J].Clin Infect Dis,2007,45(Suppl 2):S99-S111.

共引文献41

同被引文献9

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部